182 related articles for article (PubMed ID: 21786026)
1. Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.
Petrušić V; Zivković I; Stojanović M; Stojićević I; Marinković E; Inić-Kanada A; Dimitijević L
Immunol Res; 2011 Oct; 51(1):97-107. PubMed ID: 21786026
[TBL] [Abstract][Full Text] [Related]
2. Crossreacting idiotypes of kappa-monoclonal immunoglobulins M in sera of patients with Waldenström's macroglobulinemia.
Wehmeier U; Rilke H; Patzold U; Schedel I; Deicher H
Immunobiology; 1987 Dec; 176(1-2):144-53. PubMed ID: 2834288
[TBL] [Abstract][Full Text] [Related]
3. IgM molecules with and without J chain in serum and after purification, studied by ultracentrifugation, electrophoresis, and electron microscopy.
Eskeland T; Christensen TB
Scand J Immunol; 1975; 4(3):217-28. PubMed ID: 807966
[TBL] [Abstract][Full Text] [Related]
4. Expression of Y7 cross-reactive idiotope on human IgM molecules.
Dimitrijević LA; Stojanović M; Cirić B; Radulović M; Stojanović R; Popović Z; Inić-Kanada A; Zivković I
Immunol Invest; 2004 Feb; 33(1):1-14. PubMed ID: 15015828
[TBL] [Abstract][Full Text] [Related]
5. Hexameric immunoglobulin M in humans: desired or unwanted?
Petrušić V; Živković I; Stojanović M; Stojićević I; Marinković E; Dimitrijević L
Med Hypotheses; 2011 Dec; 77(6):959-61. PubMed ID: 21903335
[TBL] [Abstract][Full Text] [Related]
6. At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity.
Oskam N; Ooijevaar-de Heer P; Derksen NIL; Kruithof S; de Taeye SW; Vidarsson G; Reijm S; Kissel T; Toes REM; Rispens T
J Immunol; 2022 Jul; 209(1):16-25. PubMed ID: 35705253
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antibody reactivities toward self antigens of IgM of patients with Waldenström's macroglobulinemia.
Lacroix-Desmazes S; Mouthon L; Pashov A; Barreau C; Kaveri SV; Kazatchkine MD
Int Immunol; 1997 Aug; 9(8):1175-83. PubMed ID: 9263015
[TBL] [Abstract][Full Text] [Related]
8. Waldenström's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients.
Dellagi K; Dupouey P; Brouet JC; Billecocq A; Gomez D; Clauvel JP; Seligmann M
Blood; 1983 Aug; 62(2):280-5. PubMed ID: 6307428
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence that J chain regulates the polymeric structure of IgM in antibody-secreting B cells.
Randall TD; Brewer JW; Corley RB
J Biol Chem; 1992 Sep; 267(25):18002-7. PubMed ID: 1517233
[TBL] [Abstract][Full Text] [Related]
10. Changes in composition of IgM polymers in patients suffering from recurrent urinary bacterial infections after bacterial immunization treatment.
Petrušić V; Stojanović M; Zivković I; Inić-Kanada A; Dimitrijević L
Immunol Invest; 2010; 39(8):781-95. PubMed ID: 20718658
[TBL] [Abstract][Full Text] [Related]
11. Severe immune thrombocytopenia secondary to Waldenström's macroglobulinemia with anti-GPIb/IX monoclonal IgM antibody.
Yamanouchi J; Hato T; Niiya T; Azuma T; Yasukawa M
Ann Hematol; 2014 Apr; 93(4):711-2. PubMed ID: 23892928
[No Abstract] [Full Text] [Related]
12. Evidence for the biclonal nature of a Waldenstrom's macroglobulinemia.
Bonewald L; Virella G; Wang AC
Clin Chim Acta; 1985 Feb; 146(1):53-63. PubMed ID: 3921286
[TBL] [Abstract][Full Text] [Related]
13. Two IgM paraproteins differing in carbohydrate content in a patient with Waldenström's macroglobulinemia.
Virella G; Lechner MC
Clin Chim Acta; 1976 Mar; 67(2):137-44. PubMed ID: 813915
[TBL] [Abstract][Full Text] [Related]
14. Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström's macroglobulinemia.
Hummel KM; von Ahsen N; Kühn RB; Kaboth U; Grunewald RW; Oellerich M; Müller GA
Nephron; 2000 Oct; 86(2):188-9. PubMed ID: 11014992
[No Abstract] [Full Text] [Related]
15. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
[TBL] [Abstract][Full Text] [Related]
16. The biological effects of IgM hexamer formation.
Randall TD; King LB; Corley RB
Eur J Immunol; 1990 Sep; 20(9):1971-9. PubMed ID: 2120070
[TBL] [Abstract][Full Text] [Related]
17. Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM.
Hughey CT; Brewer JW; Colosia AD; Rosse WF; Corley RB
J Immunol; 1998 Oct; 161(8):4091-7. PubMed ID: 9780180
[TBL] [Abstract][Full Text] [Related]
18. Waldenström's macroglobulinemia and myasthenia gravis.
Bartoloni C; Scoppetta C; Flamini G; Guidi L; Bartoccioni E; Lambiase M; Gambassi G; Terranova T
J Clin Lab Immunol; 1981 Nov; 6(3):275-8. PubMed ID: 6802976
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
[TBL] [Abstract][Full Text] [Related]
20. J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.
Randall TD; Parkhouse RM; Corley RB
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):962-6. PubMed ID: 1736312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
